Myriad Genetics Inc (MYD.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
As of 08:06AM CEST. Market open.
| Previous close | 17.80 |
| Open | 18.00 |
| Bid | 18.50 x N/A |
| Ask | 18.70 x N/A |
| Day's range | 18.00 - 18.00 |
| 52-week range | 13.20 - 22.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
Myriad (MYGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Myriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.
- Zacks
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.
© 2024 Yahoo. All rights reserved.